Gastrointestinal Motility Disorders in the Neonate

Kathryn Hawa1, Shamaila Waseem1, Joseph Croffie1

  • 1Division of Gastroenterology, Hepatology, and Nutrition, Riley Hospital for Children, Indiana University Health, Indiana University School of Medicine, Indianapolis, Indiana.

Neoreviews
|February 28, 2025
PubMed

Insights

Gastrointestinal motility disorders in infants can arise from various factors, including prematurity and congenital anomalies. Understanding normal development aids in diagnosing and managing these complex pediatric conditions.

Area of Science:

  • Pediatric Gastroenterology
  • Neonatal Physiology
  • Developmental Biology

Background:

  • Gastrointestinal (GI) motility disorders present unique challenges in both term and premature infants.
  • The timing of onset can vary depending on gestational age and developmental stage.
  • Congenital anomalies can significantly impact an infant's GI neuromuscular development.

Purpose of the Study:

  • To elucidate the relationship between gestational age and the presentation of GI motility disorders in infants.
  • To highlight the importance of understanding normal GI neuromuscular development for diagnosing dysmotility.
  • To provide insights into the prognosis and management strategies for infants with GI dysmotility and congenital anomalies.

Main Methods:

  • Review of current literature on infant GI motility and neuromuscular development.
  • Analysis of clinical presentations of GI dysmotility in term and premature infants.
  • Correlation of developmental abnormalities and gestational age with motility patterns.

Main Results:

  • GI motility disorders manifest differently based on gestational age and developmental timeline.
  • Deviations from normal neuromuscular development are key indicators of dysmotility.
  • Premature infants and those with congenital anomalies exhibit altered GI motility requiring specialized evaluation.

Conclusions:

  • Knowledge of normal GI neuromuscular development is crucial for accurate diagnosis and prognosis in infants.
  • Advanced testing and a multidisciplinary approach are essential for managing complex cases of infant GI dysmotility.
  • Early identification and intervention can improve outcomes for affected neonates.

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
238
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
233
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
202
Gastric Motility01:16

Gastric Motility

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
324
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
36
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
158